17
Aug 2021
Fundraising launched for University of Leeds-led Sativex brain tumour trial
A bid has been launched to fund a medical trial of a cannabis-based mouth spray in treatment of the most aggressive form of brain tumour. Researchers are looking into the use of cannabinoid-containing Sativex alongside chemotherapy treatment against recurrent glioblastoma. Around 2,200 patients are diagnosed with this type of brain tumour each year…

